Valuation: TAUNS Laboratories,Inc.

Market Cap 5.19TCr 33Cr 29Cr 27Cr 25Cr 46Cr 3.11TCr 47Cr 321.86Cr 129.74Cr 1.64TCr 123.44Cr 120.81Cr P/E 2026 *
9.77x
P/E 2027 * 16.1x
Enterprise Value 5.99TCr 38Cr 34Cr 31Cr 28Cr 53Cr 3.59TCr 54Cr 371.42Cr 149.72Cr 1.9TCr 142.45Cr 139.42Cr EV / Sales 2026
-
EV / Sales 2027 * 3.89x
Free-Float
30.14%
Yield 2026 *
7.26%
Yield 2027 * 5.86%
1 day-1.02%
1 week-3.19%
Current month-1.02%
1 month-4.52%
3 months+2.75%
6 months-0.61%
Current year-4.52%
1 week 485
Extreme 485
499
1 month 485
Extreme 485
525
Current year 463
Extreme 463
568
1 year 463
Extreme 463
577
3 years 401
Extreme 401
733
5 years 401
Extreme 401
733
10 years 401
Extreme 401
733
Manager TitleAgeSince
Chief Executive Officer 51 01/05/2014
General Counsel 58 -
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member 51 01/05/2014
Director/Board Member 53 01/04/2016
Director/Board Member 43 01/09/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.02%-3.19%-12.43% - 33Cr
+3.73%+5.03%-10.89%+14.80% 19TCr
+2.85%+4.75%+9.47%+37.73% 12TCr
+5.12%+0.22%-13.88%+10.27% 12TCr
-0.54%+2.31%-41.32%+6.75% 9.62TCr
+2.12%+2.38%+0.01%+75.79% 6.45TCr
-5.48%-5.11%-1.24%+61.88% 5.25TCr
+0.36%+1.13%+11.13%-22.40% 5.41TCr
+21.85%+17.79%+6.69%+60.13% 5.29TCr
-0.94%+3.89%+1.46%-10.74% 3.56TCr
Average +2.81%+3.16%-5.10%+26.02% 7.85TCr
Weighted average by Cap. +3.31%+3.94%-7.11%+24.18%

Financials

2026 2027 *
Net sales 1.48TCr 9.35Cr 8.35Cr 7.66Cr 6.97Cr 13Cr 885.12Cr 13Cr 91Cr 37Cr 467.18Cr 35Cr 34Cr 1.61TCr 10Cr 9.11Cr 8.36Cr 7.6Cr 14Cr 965.56Cr 15Cr 100Cr 40Cr 509.63Cr 38Cr 37Cr
Net income 520.13Cr 3.3Cr 2.94Cr 2.7Cr 2.46Cr 4.6Cr 312Cr 4.7Cr 32Cr 13Cr 164.68Cr 12Cr 12Cr 321.14Cr 2.03Cr 1.82Cr 1.67Cr 1.52Cr 2.84Cr 192.63Cr 2.9Cr 20Cr 8.03Cr 101.67Cr 7.64Cr 7.47Cr
Net Debt 799.4Cr 5.07Cr 4.52Cr 4.15Cr 3.77Cr 7.08Cr 479.51Cr 7.22Cr 50Cr 20Cr 253.09Cr 19Cr 19Cr 1.07TCr 6.76Cr 6.04Cr 5.54Cr 5.04Cr 9.45Cr 640Cr 9.63Cr 66Cr 27Cr 337.8Cr 25Cr 25Cr
Projected Income Statement - Annual - TAUNS Laboratories,Inc.
Logo TAUNS Laboratories,Inc.
Tauns Laboratories Inc is a Japan-based company engaged in the business of developing, manufacturing and marketing in vitro diagnostic products and research reagents. The Company operates its business in the in vitro diagnostic products business segment. The Company’s main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.
Employees
218
Date Price Change Volume
02/26/02 JP¥486.00 -1.02% 1,37,900
30/26/30 JP¥491.00 -0.20% 1,05,300
29/26/29 JP¥492.00 0.00% 2,05,300
28/26/28 JP¥492.00 -1.20% 2,04,600
27/26/27 JP¥498.00 -0.80% 1,45,500
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - TAUNS Laboratories,Inc.
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
486.00JPY
Average target price
420.00JPY
Spread / Average Target
-13.58%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - TAUNS Laboratories,Inc.
  1. Stock Market
  2. Stocks
  3. 197A Stock